Bang & Olufsen A/S
Major Shareholder Announcement
Major Shareholder Announcement
Bang & Olufsen A/S has pursuant to the Danish Capital Markets Act received a major shareholder announcement from UBS Group AG.
- As per 4 February 2025, UBS Group AG's holding of other financial instruments according to section 39 of the Capital Markets Act was above 5 per cent.
As per 4 February 2025, UBS Group AG holds according to section 38 of the Capital Markets Act, and other financial instruments according to section 39 of the Danish Capital Markets Act, 8,216,091 shares and voting rights in Bang & Olufsen A/S corresponding to 5.58 per cent of the total number of shares and voting rights.
For further information, please contact:
Cristina Rønde Hefting
Sr. Director, Head of Strategy & Investor Relations
Phone: +45 4153 7303
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG19.10.2025 16:30:00 CEST | Press release
PSMAddition data show Novartis Pluvicto™ delays progression to end-stage prostate cancer
Genmab A/S18.10.2025 12:00:34 CEST | Press release
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom